Fattal Europe 2025: NOI Is Up, But 2026 Is Still a Refinancing Test

Company Overview

Fattal Europe is not a classic hotel operator. It is a hotel real estate owner and lessor, and the core economic model is to own assets, lease them to hotel operators from the wider Fattal group, and finance growth through a mix of bank debt, public bonds and parent-company funding. By the end of 2025 it held ownership or lease rights in 56 hotels with roughly 8,712 rooms, alongside a new acquisition wave in England and Cyprus and development or completion projects in Lisbon and Birmingham. This is not a pure tourism story. It is a rent, asset value and refinancing story.

What is working now is easy to see. Rental income rose 22.3% to EUR 66.935 million, NOI rose 22% to EUR 63.799 million, and the company’s share of investment property value climbed to EUR 1.315 billion. In the fourth quarter management was already pointing to an annualized run-rate NOI from ongoing operations of roughly EUR 66 million. On a first read, that looks like a larger, more valuable and more productive asset base.

But that first read is incomplete. Most of the 2025 growth came from acquisitions, not from stronger performance in the same assets. The company’s share of Same Property NOI rose only to EUR 58.199 million from EUR 57.642 million, just 1% growth, while its share of total NOI jumped to EUR 73.027 million from EUR 61.269 million. In other words, the story is not mainly that the existing portfolio suddenly became much better. It is that the portfolio became much bigger, especially in the UK, and the financing layer grew with it.

That is why the active bottleneck is not occupancy or hotel demand. The bottleneck is the 2026 funding test. Current liabilities jumped to EUR 209.420 million from EUR 86.861 million, and the group reported a working capital deficit of roughly EUR 154 million. Within that, about EUR 79 million relates to loans on 13 hotels in Germany and the Netherlands that mature between September and December 2026, and another roughly EUR 54 million is the final repayment of Bond Series D at the end of September 2026. So 2025 looks like an expansion year, but 2026 will be judged as a refinancing proof year.

There is also an important actionability filter here. The company is listed in Tel Aviv only through its bonds. There is no traded equity line and there are no short-interest data. So the market read is not going to run through equity multiple expansion or stock sentiment. It will run through refinancing access, bond issuance conditions, rating stability and whether the wider Fattal group remains a helpful operational and funding anchor rather than becoming a heavier point of dependence.

The quick economic map looks like this:

It is also important to understand contract quality. Out of the 56 hotels, 54 are leased to Fattal group operating entities or related companies, usually for roughly 20 years with a 5-year extension option, and seven UK hotels are on 30-year leases with a further 5-year option. In most contracts, rent is not just flat base rent. It includes a fixed component that is partly indexed to local CPI at 75% to 80% of the annual change, and a variable component above a sales threshold. That improves contract quality. It does not diversify tenant risk, because almost all of it still sits against the same broader group.

Events And Triggers

The first trigger: 2025 was an aggressive acquisition year, mainly in England. During the year the company completed acquisitions in Liverpool, Heathrow, Southampton, Exeter and Chester, alongside a hotel purchase in Protaras, Cyprus. In December 2025 it also bought the remaining 49% in Leonardo Haymarket for roughly GBP 19.9 million and began fully consolidating the asset. The economic meaning is straightforward: 2025 bought future NOI, but it also built a heavier funding layer before the new assets even contributed a full year.

The second trigger: the company tapped the debt market more than once. In March 2025 it issued NIS 223.674 million nominal of Series F bonds at a 5.59% interest rate. In November 2025 another NIS 205.971 million nominal of the same series was listed. After the balance-sheet date, in February 2026, the company completed another Series F expansion of roughly EUR 78 million. That matters because it shows the local bond market is still open to the issuer. It also shows that the company is actively using that channel, not just keeping it as optionality.

The third trigger: the parent moved from being a backstop to being an active funding layer. A EUR 50 million credit line was approved in November 2024, and another EUR 70 million line was approved in November 2025. The interest rate was cut to 4.7% from 5.8%, and the year-end payable to the parent reached EUR 59.409 million versus EUR 16.845 million a year earlier. That clearly helps liquidity. It also means the company’s funding thesis depends more on the wider Fattal group, not less.

The fourth trigger: Corpus Christi in Lisbon still produces no income, but it matters to the forward picture. The as-is fair value rose to EUR 66.860 million and the value on completion was estimated at EUR 89.984 million. At the same time, construction costs rose roughly 45% above the original budget and total hotel cost is now expected to reach about EUR 77.2 million. Opening is planned for September 2026. That asset can strengthen both collateral and future NOI, but for now it still consumes attention and capital.

The fifth trigger: the investment period of Partnership 01/2024 is expected to end in the second quarter of 2026, while the company has already started building Partnership VI with expected equity of EUR 600 million to EUR 1 billion. This matters because the company is still trying to grow through institutional partnerships as well. The open question is whether those vehicles truly lighten the risk profile, or whether they mainly add another layer of look-through complexity and leverage.

Efficiency, Profitability And Competition

Growth was acquisition-led, not organic

The cleanest way to read 2025 is to compare total NOI with Same Property NOI. Total NOI rose to EUR 63.799 million from EUR 52.313 million, up 22%. But consolidated Same Property NOI rose only to EUR 59.480 million from EUR 58.808 million, and the company-share figure rose to just EUR 58.199 million from EUR 57.642 million.

That is the point a quick first read can miss. 2025 does not prove the existing portfolio suddenly became much stronger. It proves the company enlarged the portfolio, especially in the UK, and that the enlarged base started flowing into the reported numbers. That is constructive, but it is not the same thing as broad organic strengthening.

The portfolio is now much more UK-weighted

The mix really changed in 2025. In 2024 England, Scotland and Ireland represented 30% of the company’s share of investment property value and 23% of NOI. In 2025 that became 41% of value and 31% of NOI. Germany, by comparison, moved down to 29% of value and 38% of NOI, from 35% and 41% a year earlier. At the revenue level, England and Scotland nearly doubled to EUR 20.620 million from EUR 10.876 million.

That does not mean this stopped being a German-heavy story. Germany still generates the largest NOI contribution. But it does mean the new Fattal Europe story is more British than it used to be, and more dependent on a single year’s acquisition wave. Anyone still reading the company mainly through Germany is missing the portfolio shift.

Recurring earnings improved, but not as much as net income suggests

Net income rose to EUR 69.577 million, up 66.3%. That is a strong headline, but it needs decomposition. Revaluation gains on investment property were EUR 41.403 million, and the company’s share of profit from equity-accounted entities added another EUR 5.833 million. Against that, net finance expense climbed to EUR 37.879 million from EUR 28.318 million. So a meaningful part of the earnings improvement came from revaluation and from a larger asset base, while the cost of funding was already rising.

That is where FFO matters. Statutory FFO rose to EUR 33.800 million from EUR 24.290 million, and management FFO rose to EUR 32.381 million from EUR 22.657 million. That is real improvement. But there is a nuance that matters: statutory FFO in 2025 was still basically flat against 2023. So the recurring layer is not yet confirming a structural step-up at the same pace as reported net income.

The cost of the acquisition year is already showing up in finance expense. Finance expense on long-term loans rose to EUR 23.425 million from EUR 15.899 million, and fourth-quarter net finance expense reached EUR 10.954 million, about 10% above the third quarter. That leads to the right question: who paid for the growth? The answer is that new assets pushed rent upward, but part of that benefit was already absorbed by financing costs.

On competition, the company itself points to the right battleground. This is not mainly about hotel operations. It is about sourcing and transacting on assets, reacting quickly, accessing financing and using the operating arm of the wider group. That is a real strength. But it also has a clear opposite side: the same operating platform that helps with acquisitions and lease structure also creates very high related-party concentration.

Cash Flow, Debt And Capital Structure

The right framing here is all-in cash flexibility, not normalized cash generation. 2025 was a heavy acquisition year, so the relevant question is not how much accounting profit or NOI the portfolio produced. It is how much flexibility remained after actual investment outlays, debt service and real cash uses.

Cash flow from operations rose to EUR 57.539 million from EUR 38.591 million. That is solid. But it did not fund the year. Investing cash outflow was EUR 212.800 million, mainly for six hotel acquisitions in England, the Protaras hotel and ongoing investment property development. That gap was covered by EUR 172.872 million of financing inflow, mainly from new bonds, Series F expansions, parent-company loans and new bank debt tied to acquired hotels.

That is the core cash-flow point. Cash was not built by the rental layer alone. It was preserved through a mix of operating cash and fresh financing. So it would be too strong to say the company fully self-funds this pace of expansion. The better reading is that operating cash generation is good, but the company still needs the bond market, the banks and the parent to get through a year like 2025 without liquidity pressure.

Covenants are comfortable, but 2026 is a refinancing test, not a covenant test

On this dimension the company looks much more comfortable than the working capital deficit implies. Equity-to-balance stood at 37.88%, well above covenant thresholds ranging from 22.5% to 28% across the different bond series. Adjusted net debt to adjusted NOI also looks far from pressure, at 8.09 under the Series C definition and 11.12 under the broader Series D definition. In both cases the company remains comfortably within ceilings of 15 to 17.

The gap between 8.09 and 11.12 is important in its own right. It says the simple consolidated view is more comfortable than the look-through view that captures a broader debt picture. That is not a red flag by itself, because both readings are still comfortable. But it does mean the true economic leverage is higher than a quick read of the consolidated balance sheet alone would suggest.

The near-term debt layer is where the sensitivity sits

At year-end the company itself breaks the working capital deficit into three major pieces: about EUR 54 million of final repayment on Series D in September 2026, about EUR 79 million of bank loans on 13 hotels in Germany and the Netherlands maturing between September and December 2026, and other current bond maturities. Against that, it presents several solution sources: Series D collateral assets worth roughly EUR 155 million, 13 hotels worth roughly EUR 228 million at a current LTV of about 34% that management wants to refinance at around 65%, six unencumbered assets worth about EUR 41 million, additional assets worth about EUR 92 million financed at an average LTV of around 36% that management also wants to refinance up to around 65%, unused parent-company credit capacity of about EUR 90 million as of the report-signing date, and the February 2026 Series F expansion.

That is a reasonable liquidity case, but it also reveals where the true risk lives. The company does not need a covenant breach to face pressure. It needs its refinancing plan to work on time and at an acceptable price. If that happens, the working capital deficit will look technical. If it does not, the exact same balance-sheet number will be read very differently.

The parent relationship improved flexibility, but deepened dependence

The year-end payable to the parent rose to EUR 59.409 million, and finance expense on the parent-company loan reached EUR 1.291 million in 2025. At the same time, related-party rental income was EUR 63.314 million out of total rental income of EUR 66.935 million. In addition, the parent, Fattal Holdings and the management partnership provided guarantees of up to roughly EUR 70 million to the group’s banks.

That cuts both ways. On one side, this is a real backstop. Not every local bond issuer has a funding line, guarantees and an anchor tenant from the same ecosystem. On the other side, it means Fattal Europe’s credit profile depends heavily on the ability and willingness of the broader Fattal group to keep playing three roles at once: tenant, guarantor and lender. That is not accidental dependence. It is the company’s economic structure.

Outlook

Before getting into the forward read, the five findings that really drive the 2026 interpretation are these:

1. 2025 was more of an acquisition year than an organic-improvement year. Same-property NOI barely moved.
2. Net income looked much stronger than the recurring layer. FFO improved, but not at the same pace as reported earnings.
3. The next problem is refinancing, not covenants. The company is far from covenant thresholds, but close to a dense 2026 maturity window.
4. The relationship with the Fattal group strengthened on both sides. More rent, more loans and more guarantees.
5. The fourth quarter already hints at what the market will test in 2026. Rental income held up, but finance expense kept rising and reported profit came back down after a revaluation-heavy third quarter.

That leads to a clear forward classification. 2026 is not a clean breakout year. It is a bridge year with a financing proof test. What should work in it? A full-year contribution from part of the 2025 acquisitions, full consolidation of Haymarket and its lease reset in March 2026, an annualized NOI run-rate around EUR 66 million based on the fourth quarter, and continued access to the local debt market and the banks. What is still not clean? Refinancing the 13 loans, the Series D repayment, ongoing Lisbon funding needs, and the fact that the parent support layer remains relevant even when the bond market is open.

There is also an important gap between value created and value accessible. Investment property value increased, and UK asset value rose sharply. But for bondholders and for the relevant local market audience, the key question is not whether the value exists. It is whether that value can be refinanced in time, without giving up too much cushion and without shifting even more weight to the parent. That is the practical difference between accounting value and real funding flexibility.

What has to happen over the next two to four quarters for the thesis to strengthen? First, the company needs to show that refinancing of the Germany and Netherlands loan bucket is progressing roughly as presented. Second, Series D needs to get through 2026 without the Lisbon collateral becoming a bigger question than the answer. Third, the newly acquired UK and Cyprus assets need to show that higher NOI still reaches the FFO layer after financing costs, rather than simply enlarging the balance sheet. Fourth, the parent-company lines need to remain a backstop, not become a permanent replacement for the market.

What could improve the near-term market read? Successful refinancing, further Series F access at acceptable rates, rating stability, and evidence that the newly acquired NOI is translating into FFO rather than only into revaluation and scale. What could weigh on it? Any refinancing delay, another leg up in finance expense, deeper reliance on the parent, or further slippage in Lisbon timing and cost.

Risks

The first and most obvious risk is funding and timing risk. The company lays out a reasonable answer to the working capital deficit, but every part of that answer depends on execution: bank refinancing, re-pledging, local debt issuance and possible use of the parent lines. That is a different kind of risk from covenant risk, but it is the live risk for 2026.

The second risk is concentration on the wider Fattal group. Almost 95% of 2025 rental income came from related parties, 54 of the 56 hotels are leased to group or group-related operators, and the parent stands as lender and guarantor as well. That creates a real moat. It also creates deep concentration. If the wider group’s credit profile or financial flexibility weakens, Fattal Europe would feel it through several layers at once.

The third risk is development and completion risk. Corpus Christi in Lisbon still generates no income, construction cost there is roughly 45% above the original budget, and total project cost is expected to reach about EUR 77.2 million. The Birmingham Turn Key asset will only be delivered in the first quarter of 2028. That means part of the future value the market may want to credit is still not sitting in a current cash layer.

The fourth risk is structural risk inside the financing package. The company itself highlights cross-default language and other technical acceleration triggers, and some of the loans use cross-collateral structures across several assets. Management argues the probability of a real event remains low. Even so, in a year defined by refinancing, technical debt structure deserves closer attention than usual.

It is also worth saying what looks less central right now. Rate risk is not the main issue because most debt carries fixed interest. FX risk against the shekel also looks limited relative to the broader thesis, because only about NIS 206 million nominal of bond principal was described as not yet hedged and management does not expect a material effect from EUR/ILS moves. So this is not primarily a currency story. It is a capital structure story.

Conclusions

Fattal Europe ends 2025 with a larger portfolio, stronger NOI and funding access that still looks open. That is the supportive side of the thesis. The main blocker remains the 2026 test: a dense refinancing window, a large working capital deficit and deep dependence on the wider Fattal group as tenant, lender and guarantor. What will shape the market read over the near to medium term is not mainly the accounting value of the assets. It is whether the company can turn higher NOI into real funding flexibility.

Current thesis: 2025 strengthened Fattal Europe’s asset base, but it also made it clearer that real credit quality will be judged by refinancing execution and by whether dependence on the parent stops rising from here.

What changed versus the earlier read of the company? Through 2024 this was mostly an asset owner with comfortable covenant room. After 2025 it is an asset owner that moved sharply toward the UK, bought a lot of future NOI, and now has to prove the funding structure can keep up with the enlarged portfolio.

The strongest counter-thesis is that the market may be too conservative. The company has a 37.88% equity-to-balance ratio, meaningful unencumbered or low-LTV assets, comfortable collateral values, proven local bond access and parent support. If so, 2026 may end up looking like a technical refinancing cycle rather than a real pressure point.

What could change the market interpretation over the near to medium term? Successful refinancing of the 13-hotel bank loan bucket, continued access to Series F, rating stability, and proof that newly acquired NOI remains strong after funding costs. What would weaken the thesis? Refinancing delays, another step up in finance expense, deeper use of the parent as a permanent funding source, or further Lisbon cost slippage.

Why does this matter? Because in Fattal Europe the question is not whether the assets are good. The question is whether that asset value is actually available to serve debt on time and on terms that do not eat away the safety margin.